Management of Diabetic Trigger Finger.
A1 release
corticosteroid injection
cost analysis
diabetes
trigger finger
Journal
The Journal of hand surgery
ISSN: 1531-6564
Titre abrégé: J Hand Surg Am
Pays: United States
ID NLM: 7609631
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
10
10
2017
accepted:
23
03
2018
pubmed:
21
5
2018
medline:
21
1
2020
entrez:
21
5
2018
Statut:
ppublish
Résumé
Diabetics have a much greater prevalence of trigger finger than nondiabetics and are more likely to have severe symptoms. Diabetic trigger finger may be more accurately described on a spectrum of diabetic hand pathology alongside carpal tunnel syndrome and cheiroarthropathy. Recent publications have called into question the current treatment algorithm for diabetic trigger finger. Although some evidence supports the use of corticosteroid injections, a recent cost analysis reported that immediate surgical release of the A1 pulley in the clinic is the most cost-effective management of diabetic trigger finger. In addition to traditional treatment with injection and open release, percutaneous release with or without simultaneous corticosteroid injection has shown promising results and may have a role in patient care. The appropriate treatment algorithm in terms of efficacy, safety, and cost remains controversial.
Identifiants
pubmed: 29778347
pii: S0363-5023(17)31769-0
doi: 10.1016/j.jhsa.2018.03.045
pii:
doi:
Substances chimiques
Glucocorticoids
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
150-153Informations de copyright
Copyright © 2019 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.